Synacthen, Injektionslösung
7680317230012
CH-31723
Injektionslösung
Associated product:
SYNACTHEN 0.25 mg/ml i.m./i.v. amp 1 ml
1 / 3
google
Article details
- Package size
- 1 x 1 ml
- Selling units
- 1
- Measure
- Ampulle(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
tetracosactidum
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
tetracosactidi hexaacetas
|
- | Substance | WIZUS |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
3.34 MG | Substance | HBESI |
Authorization holder
Atnahs Pharma Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 31723
- Drug name
- Synacthen, Injektionslösung
- Galenic form
- LSIN
- ATC Code
- H01AA02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/11/1965
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.07.1.
- Domain
- Human medicine
Package details
- Description (FR)
- SYNACTHEN 0.25 mg/ml i.m./i.v. amp 1 ml
- Description (DE)
- SYNACTHEN 0.25 mg/ml i.m./i.v. Amp 1 ml
- Market launch
- 18/11/1965
- Narcotic (BTM)
- No
Other package sizes (1)
SYNACTHEN sol inj 0.25 mg/ml i.m./i.v. 10 amp 1 ml
None None
GTIN: 7680317230272